What it's actually good for
Alpha-lipoic acid (ALA) is a sulfur-containing compound your body makes in small amounts and uses as a cofactor for mitochondrial enzymes. What makes it interesting as a supplement is that it's active in both water and fat — most antioxidants are one or the other — so it reaches compartments vitamin C and vitamin E can't, and it helps regenerate both of them along with glutathione. That mechanism is well established. Whether it translates into meaningful clinical benefit is more mixed than the supplement-aisle framing suggests, and the honest answer depends on which outcome you're asking about.
What the research says
Diabetic neuropathy (Grade B — real signal, weaker than the older headline trials suggest). The case for ALA and nerve pain traces back to a 2004 meta-analysis by Ziegler and colleagues: four RCTs, 1,258 patients, 600 mg given intravenously for three weeks, showing a 24% relative reduction in symptom scores and a responder rate of 53% versus 37% on placebo. That's a real effect — but it's IV dosing under a short, supervised course, not the oral capsules sold as supplements. A 2024 Cochrane review that focused specifically on oral ALA (3 RCTs, 816 participants) reached a more sobering conclusion: moderate-certainty evidence that oral ALA "probably has little or no effect" on neuropathy symptoms or impairment at six months. Read together, ALA has a plausible, IV-demonstrated effect on nerve symptoms over short courses, but the oral form most people actually buy has much thinner support.
Blood sugar and metabolic effects. NCCIH's supplement guidance is blunt here: in the trials it reviewed, ALA was no better than placebo at lowering blood sugar. A separate meta-analysis (Kucukgoncu et al., 2017, 10 RCTs) did find a modest weight-loss effect — about 1.3 kg more than placebo and a small BMI reduction — but the authors themselves called the clinical significance limited. This isn't a blood-sugar or weight-loss supplement; any metabolic benefit is small.
General antioxidant use. ALA reliably lowers oxidative-stress markers in blood tests — a real, reproducible finding. That's a biomarker change, though, not a proven downstream health outcome for people without a specific deficiency or condition, the same caveat that applies to most standalone antioxidant supplements.
Cognitive support. This is the thinnest part of the file. ALA has mostly been tested in Alzheimer's disease, not in healthy people looking for a cognitive edge, and results there are inconsistent — one trial combining ALA with vitamins E and C saw cognition worsen despite lower oxidative-stress markers, while ALA paired with omega-3s slowed decline in another small trial. There's no trial evidence it helps memory or focus in healthy adults; treat any cognitive claim as speculative.
How much, and which form
The clinical trials with the clearest results used 600 mg delivered intravenously under supervision for a few weeks — not something you replicate with a capsule. Oral supplements typically supply 300-600 mg/day for general use, with some neuropathy-focused products going to 600-1,200 mg/day; take on an empty stomach, since food reduces absorption. R-lipoic acid is the form your body naturally produces, but the racemic R/S mixture is what's actually been used in nearly all the human trials above, so it's the better-evidenced choice despite being less "pure."
Safety & interactions
ALA is generally well tolerated — mild GI upset, rash, or headache are the most common complaints. Because it can lower blood sugar, anyone on insulin or a glucose-lowering medication should monitor levels closely; very high doses have rarely been linked to a serious insulin autoimmune reaction. It can also lower thyroid hormone levels, so separate dosing from levothyroxine. This is informational, not medical advice — check with a clinician before starting.
How we picked the brand
An ALA product earns a spot when it clearly states the R/S ratio, is GMP-certified or independently tested, and doesn't inflate the dose with proprietary blends.